The information contained on this page is intended
for US healthcare professionals only.  Patient site

The information contained on this page is intended
for US healthcare professionals only.  Patient site

The full clinical story of vazalore® IS ONE OF innovative technology

PAPERS

Pharmacokinetic and pharmacodynamic profile of a novel phospholipid aspirin formulation.
Angiolillo DJ, et al. Clin Pharmacokinet. 2022:1-15. Published online January 20, 2022. doi:10.1007/s40262-021-01090-2
Influence of lipid excipients on platelet function and the pharmacodynamic effects of aspirin.
Schneider DJ, et al. J Cardiovasc Pharmacol. 2021;78(2):297-301.

POSTERS/ABSTRACTS

Impact of sex on platelet inhibition by aspirin in obese patients with type 2 diabetes: a pooled, patient-level analysis of two randomised clinical trials.

Kimmelstiel C, et al. EuroIntervention. 2020;16(suppl AC):382.
Abstract accepted at: EuroPCR; May 19-22, 2020.

Hospital budget impact of switching to an alternative aspirin formulation with improved GI safety for treatment of acute cardiovascular events.

Chingcuanco F, et al. Value Health. 2019;22(suppl S2):S123.
Poster presented at: ISPOR; May 18-22, 2019; New Orleans, LA.

Limitations of enteric-coated aspirin underscore the need for a next generation, safer and effective aspirin option.

Chingcuanco F, et al. Value Health. 2019;22(suppl S2):S121.
Poster presented at: ISPOR; May 18-22, 2019; New Orleans, LA.

Improved pharmacologic profile of a novel, liquid aspirin formulation compared with enteric coated aspirin: a pooled, patient level analysis of two randomized crossover studies.

Bhatt DL, et al. J Am Coll Cardiol. 2020;75(11 suppl 1):29.
Poster presented at: American College of Cardiology’s 69th Annual Scientific Session & Expo; March 28-30, 2020; Chicago, IL.

Impact of weight on the antiplatelet effects of aspirin: results of a pooled analysis of two randomized crossover studies comparing a liquid aspirin formulation with enteric coated aspirin.

Bhatt DL, et al. J Am Coll Cardiol. 2020;75(11 suppl 1):1344.
Poster presented at: American College of Cardiology’s 69th Annual Scientific Session & Expo; March 28-30, 2020; Chicago, IL.

Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation.

Angiolillo DJ, et al. Stroke. 2020;51:ATP432.
Poster presented at: International Stroke Congress (ISC); February 18-21, 2020; Los Angeles, CA.

Pharmacokinetic and pharmacodynamic assessment of a lipid-based aspirin formulation: results of a prospective, randomized, crossover study.

Angiolillo DJ, et al. Eur Heart J. 2019;40(suppl):1225.
Poster presented at: European Society of Cardiology Congress (ESC); August 31-September 4, 2019; Paris, France.

Have questions or want to learn more about PLx Pharma Inc. or VAZALORE? Call 1-888-842-3567 or
request to be contacted
by a VAZALORE Representative.

Learn how
VAZALORE works

 

Read VAZALORE 325 mg clinical results
 
 

Opportunity for innovation in
aspirin delivery